Indian drugmakers support for temporary sales disruptions due to Ukraine crisis

Indian pharmaceutical major Dr. Reddy's Laboratories Ltd said it is focused on business continuity in and around Russia, as Indian drug exporters’ brace for temporary disruptions to sales due to the Ukraine crisis. No Indian company has publicly wit.

CMC Vellore is prepared with mixed vaccine study results

Christian Medical College (CMC) Vellore will soon share preliminary results of a study to test the feasibility of mixing Covishield and Covaxin - the two main Covid-19 vaccines available in the country - with the country's drug regulator, a senior of

Natco Pharma launched its first generic cancer drug Revlimid in the US market

Natco Pharma along with its marketing partner Arrow International - an affiliate of Israeli-drug maler Teva Pharmaceutical Industries announced the launch of the first generic version of Celgene's (now acquired by Bristol Myers Squibb) top selling ca

Six pharmaceutical majors are in race to acquire Curatio Healthcare

Six pharmaceutical majors Aurobindo, Biocon, Dr Reddy's, JB Chemicals, Torrent Pharma and Zydus Healthcare have been shortlisted for the acquisition of Curatio Healthcare, the Chennai-based company focused on skincare products, multiple people aware

Booster dose: India's pharma segment to grow at 6-8% YoY in FY23

India's pharmaceuticals market (IPM) is expected to grow between 6 and 8 per cent on a year-on-year (YoY) basis in FY23. India's pharmaceuticals market (IPM) is expected to grow between 6 and 8 per cent on a year-on-year (YoY) basis in FY23.India's

Subject Expert Committee approves Covovax for 12-17 year-olds

The Subject Expert Committee (SEC) under the Central Drugs Control Standard Organisation on Friday recommended Serum Institute of India's (SII) Covid-19 vaccine, Covovax, for emergency use authorisation in the 12-17 age group, people in the know told

Top trends in the Pharmacovigilance market

The pharmacovigilance market is anticipated to register a CAGR of 10.5 percent until 2030. The rise in the incidence of ADRs is a major factor fuelling the market growth.

3 Key Areas of Focus for Pharma R&D

CARE Ratings expects India's pharma segment to develop at an annual rate of roughly 11% over the next two years, reaching a value of more than $60 billion.

Medicine retailers and distributors are against discount offers

Medicine retailers and distributors in Delhi have urged the state government to issue an order restraining online and offline pharmacies from offering discounts.Medicine retailers and distributors in Delhi have urged the state government to issue an

Brinton gets into strategic alliance with Scholl Wellness Company

Brinton, the Indian Pharmaceutical Multinational, which has been steadily increasing its footprint in the Indian and global healthcare sector, in a strategic move today announced a tie-up with the global foot care brand, Scholl Wellness Company, for

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.